RxDoctor Payments Data

Vidya Counto, MD

Family Medicine · Columbiana, OHNPI 1609097971

Payments from drug & device makers

$1,266in general payments, 2019–2025

Across 68 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$416
  • Novo Nordisk$232
  • AbbVie$148
  • GSK$109
  • Lilly USA, LLC$60
  • Pfizer$56
  • plus $246 from 10 others

What the payments were for

  • Food & beverage$1,266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,266 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,897
Medicare patients
156
Services billed
958

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$55,049
OzempicSemaglutide48$45,816
JardianceEmpagliflozin43$30,369
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$29,532
Breztri AerosphereBudesonide/Glycopyr/Formoterol39$27,722
TrulicityDulaglutide21$20,096
JanuviaSitagliptin Phosphate17$16,402
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog32$15,916
FarxigaDapagliflozin Propanediol13$12,294
NexlizetBempedoic Acid/Ezetimibe11$10,981
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$5,137
SymbicortBudesonide/Formoterol Fumarate19$4,906
Rosuvastatin Calcium433$4,013
SynthroidLevothyroxine Sodium56$3,397
Metoprolol Succinate312$3,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$55,04958 claims
Novo NordiskOzempic$232$45,81648 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$416$44,92171 claims
GSKTrelegy Ellipta$109$29,53229 claims
Lilly USA, LLCTrulicity$60$20,09621 claims
MerckJanuvia$31$16,40217 claims
Esperion Therapeutics, Inc.Nexlizet$36$10,98111 claims
AbbVieSynthroid$148$3,39756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbiana

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →